News | May 22, 2024
AstraZeneca plans $1.5 billion ADCs manufacturing facility in Singapore
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Pharma Solutions operates 10 research and development and/or production sites globally
The pilot plant is focused on scaling up beverage production and will support applications
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Subscribe To Our Newsletter & Stay Updated
